LEADER 01010nam--2200349---450 001 990001780260203316 005 20210913084400.0 035 $a000178026 035 $aUSA01000178026 035 $a(ALEPH)000178026USA01 035 $a000178026 100 $a20040622d2001----km-y0itay0103----ba 101 $aita 102 $aIT 105 $a||||||||001yy 200 1 $a<> raccolta di stili$e3 volume$fIsabella Michela Affinito 210 $aTorino$cA.L.I.$d2001 215 $a34 p.$d24 cm 225 2 $a<> nuovo confini della scrittura in versi 410 0$12001$a<> nuovo confini della scrittura in versi 454 1$12001 461 1$1001-------$12001 600 0 $aAffinito,$bIsabella Michela 676 $a851.9 700 1$aAFFINITO,$bIsabella Michela$0563446 801 0$aIT$bsalbc$gISBD 912 $a990001780260203316 951 $aXVII A.MISC. 801$b6689 DLAS$cXVII A.MISC.$d539318 959 $aBK 969 $aCAS 996 $aRaccolta di stili$9952491 997 $aUNISA LEADER 03048nam 2200517 450 001 9910446318903321 005 20230808191824.0 010 $a1-4963-4784-6 035 $a(CKB)3710000000597571 035 $a(SSID)ssj0001613613 035 $a(PQKBManifestationID)16338629 035 $a(PQKBTitleCode)TC0001613613 035 $a(PQKBWorkID)14914436 035 $a(PQKB)11335000 035 $a(MiAaPQ)EBC4850673 035 $a(Au-PeEL)EBL4850673 035 $a(CaPaEBR)ebr11380403 035 $a(OCoLC)946069325 035 $a(EXLCZ)993710000000597571 100 $a20170519h20162016 uy 0 101 0 $aeng 135 $aurcnu|||||||| 181 $ctxt 182 $cc 183 $acr 200 10$aNephrology rounds /$fDavid J. Leehey 210 1$aPhiladelphia, Pennsylvania :$cWolters Kluwer,$d2016. 210 4$dİ2016 215 $a1 online resource (174 pages) $cillustrations 300 $aBibliographic Level Mode of Issuance: Monograph 311 $a1-4963-1970-2 320 $aIncludes bibliographical references and index. 327 $aHow is the urinalysis helpful in patients with kidney disease? -- How should changes in plasma creatinine be interpreted? -- What is a fractional excretion (and how does measuring it help in clinical practice)? -- What is the urine albumin to creatinine ratio? (or is it protein to creatinine ratio?) -- What is the meaning of the urine to plasma creatinine ratio? -- Is it helpful to diagnose a triple acid-base disturbance? (or is it just a mental exercise?) -- Why are disorders of sodium concentration so difficult? -- What is free water clearance and how useful is it? -- How does one interpret the urine anion gap and urine osmolal gap? -- Is it 'acute renal failure' or 'acute kidney injury'? -- What exactly is dialysis and when is it needed? -- When does metabolic acidosis require treatment with bicarbonate? -- Is there any advantage to colloids vs. crystalloids for volume repletion? -- Is computed tomography (CT) with contrast or magnetic resonance imaging (MRI) with contrast preferred in patients with chronic kidney disease? -- Is there a risk to rapidly lowering the plasma potassium in patients with hyperkalemia? -- Should calcium-based phosphate binders be used in patients with chronic kidney disease? -- Which renal cysts require follow-up evaluation? -- Are renin angiotensin aldosterone system blockers friends or foes of the kidneys? -- Does a patient with a mild decrease in estimated glomerular filtration rate (eGFR) really have a disease? -- Why are kidney stones a nephrologic as well as a urologic disease?. 606 $aKidneys$xDiseases$xDiagnosis 606 $aKidneys$xDiseases$xTreatment 615 0$aKidneys$xDiseases$xDiagnosis. 615 0$aKidneys$xDiseases$xTreatment. 676 $a616.61075 700 $aLeehey$b David J.$01043823 801 0$bMiAaPQ 801 1$bMiAaPQ 801 2$bMiAaPQ 906 $aBOOK 912 $a9910446318903321 996 $aNephrology rounds$92469062 997 $aUNINA